Global End Stage Renal Disease Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

By Treatment;

Transplantation and Dialysis - Peritoneal Dialysis, Hemodialysis, and Wearable Artificial Kidney.

By Geography;

North America, Europe, Asia Pacific, Middle East and Africa, and Latin America - Report Timeline (2021 - 2031).
Report ID: Rn133367338 Published Date: January, 2025 Updated Date: February, 2025

Introduction

Global End Stage Renal Disease Market (USD Million), 2021 - 2031

In the year 2024, the Global End Stage Renal Disease Market was valued at USD 124,196.34 million. The size of this market is expected to increase to USD 300,427.92 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 13.5%.

The global end-stage renal disease (ESRD) market is expanding rapidly due to the increasing prevalence of chronic kidney disease (CKD) and the rising aging population worldwide. ESRD, the final stage of chronic kidney disease, requires either dialysis or a kidney transplant for patients to survive, leading to high demand for ESRD-related treatments. Factors such as poor lifestyle choices, diabetes, hypertension, and genetic predisposition are contributing to the rising number of ESRD cases globally. With over 700 million people affected by kidney disease worldwide, the demand for renal care services, dialysis machines, and kidney transplants has surged, driving market growth. The aging population is particularly vulnerable to kidney diseases, further exacerbating the market's expansion.

Dialysis is the primary treatment for ESRD, and the market for dialysis products and services constitutes a significant portion of the global ESRD market. Hemodialysis, a procedure where blood is filtered outside the body, remains the most widely used treatment, especially in developed regions. Peritoneal dialysis, which uses the lining of the abdomen to filter waste, is also gaining traction, particularly in homecare settings. Advancements in dialysis technologies, including the development of more efficient machines, wearable dialysis devices, and portable solutions, are contributing to market growth. Moreover, the increasing number of dialysis centers and government initiatives to improve access to renal care are helping drive the adoption of dialysis treatments, particularly in emerging markets.

Despite the advancements in treatment options, the global ESRD market faces several challenges, including the high cost of dialysis and the shortage of kidney donors for transplants. As dialysis requires long-term management, the ongoing costs place a significant financial burden on both patients and healthcare systems. While kidney transplantation offers a better long-term prognosis, the global shortage of transplantable organs limits the availability of this treatment option. However, innovations in kidney transplant technologies, such as the development of artificial kidneys, along with the rise of home dialysis and remote monitoring, are expected to offer new opportunities in the ESRD market. Additionally, the increasing focus on preventive healthcare, early diagnosis, and the management of risk factors such as diabetes and hypertension offers potential avenues to mitigate the rise in ESRD cases in the future.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Treatment
    2. Market Snapshot, By Region
  4. Global End Stage Renal Disease Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Increasing prevalence of chronic kidney disease (CKD) and diabetes
        2. Rising aging population and associated health risks
        3. Advancements in dialysis technologies
        4. Growing healthcare infrastructure and dialysis centers
      2. Restraints
        1. High treatment costs of dialysis and kidney transplants
        2. Shortage of kidney donors for transplantation
        3. Limited access to renal care in low-income regions
        4. Risk of complications and side effects in dialysis treatments
      3. Opportunities
        1. Innovations in artificial kidneys and bioengineered organs
        2. Growth of home dialysis and portable dialysis solutions
        3. Early detection and management of kidney diseases
        4. Expansion of healthcare access in emerging markets
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Global End Stage Renal Disease Market, By Treatment, 2021 - 2031 (USD Million)
      1. Transplantation
      2. Dialysis
        1. Peritoneal Dialysis
        2. Hemodialysis
      3. Wearable Artificial Kidney
    2. Global End Stage Renal Disease Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Medtronic

      2. Fresenius Medical Care AG & Co

      3. Kgaa

      4. B. Braun Melsungen AG

      5. Baxter International Inc

      6. Asahi Kasei Medical Co Ltd

      7. Cantel Medical Bd Nikkiso Co

      8. JMS Co Ltd

  7. Analyst Views
  8. Future Outlook of the Market